Table of Content

1 Luseogliflozin Market Overview
1.1 Product Overview and Scope of Luseogliflozin
1.2 Luseogliflozin Segment by Type
1.2.1 Global Luseogliflozin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 2.5mg
1.2.3 5mg
1.3 Luseogliflozin Segment by Application
1.3.1 Luseogliflozin Sales Comparison by Application: (2021-2027)
1.3.2 Diabetes
1.3.3 Heart Disease
1.3.4 Periodontitis
1.4 Global Luseogliflozin Market Size Estimates and Forecasts
1.4.1 Global Luseogliflozin Revenue 2016-2027
1.4.2 Global Luseogliflozin Sales 2016-2027
1.4.3 Luseogliflozin Market Size by Region: 2016 Versus 2021 Versus 2027

2 Luseogliflozin Market Competition by Manufacturers
2.1 Global Luseogliflozin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Luseogliflozin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Luseogliflozin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Luseogliflozin Manufacturing Sites, Area Served, Product Type
2.5 Luseogliflozin Market Competitive Situation and Trends
2.5.1 Luseogliflozin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Luseogliflozin Players Market Share by Revenue
2.5.3 Global Luseogliflozin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Luseogliflozin Retrospective Market Scenario by Region
3.1 Global Luseogliflozin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Luseogliflozin Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Luseogliflozin Market Facts & Figures by Country
3.3.1 North America Luseogliflozin Sales by Country
3.3.2 North America Luseogliflozin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Luseogliflozin Market Facts & Figures by Country
3.4.1 Europe Luseogliflozin Sales by Country
3.4.2 Europe Luseogliflozin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Luseogliflozin Market Facts & Figures by Region
3.5.1 Asia Pacific Luseogliflozin Sales by Region
3.5.2 Asia Pacific Luseogliflozin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Luseogliflozin Market Facts & Figures by Country
3.6.1 Latin America Luseogliflozin Sales by Country
3.6.2 Latin America Luseogliflozin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Luseogliflozin Market Facts & Figures by Country
3.7.1 Middle East and Africa Luseogliflozin Sales by Country
3.7.2 Middle East and Africa Luseogliflozin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Luseogliflozin Historic Market Analysis by Type
4.1 Global Luseogliflozin Sales Market Share by Type (2016-2021)
4.2 Global Luseogliflozin Revenue Market Share by Type (2016-2021)
4.3 Global Luseogliflozin Price by Type (2016-2021)

5 Global Luseogliflozin Historic Market Analysis by Application
5.1 Global Luseogliflozin Sales Market Share by Application (2016-2021)
5.2 Global Luseogliflozin Revenue Market Share by Application (2016-2021)
5.3 Global Luseogliflozin Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Taisho Toyama
6.1.1 Taisho Toyama Corporation Information
6.1.2 Taisho Toyama Description and Business Overview
6.1.3 Taisho Toyama Luseogliflozin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Taisho Toyama Product Portfolio
6.1.5 Taisho Toyama Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Luseogliflozin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Novartis Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Corporation Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma Luseogliflozin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Mitsubishi Tanabe Pharma Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 CR Double-Crane
6.4.1 CR Double-Crane Corporation Information
6.4.2 CR Double-Crane Description and Business Overview
6.4.3 CR Double-Crane Luseogliflozin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CR Double-Crane Product Portfolio
6.4.5 CR Double-Crane Recent Developments/Updates

7 Luseogliflozin Manufacturing Cost Analysis
7.1 Luseogliflozin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Luseogliflozin
7.4 Luseogliflozin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Luseogliflozin Distributors List
8.3 Luseogliflozin Customers

9 Luseogliflozin Market Dynamics
9.1 Luseogliflozin Industry Trends
9.2 Luseogliflozin Growth Drivers
9.3 Luseogliflozin Market Challenges
9.4 Luseogliflozin Market Restraints

10 Global Market Forecast
10.1 Luseogliflozin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Luseogliflozin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Luseogliflozin by Type (2022-2027)
10.2 Luseogliflozin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Luseogliflozin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Luseogliflozin by Application (2022-2027)
10.3 Luseogliflozin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Luseogliflozin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Luseogliflozin by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Luseogliflozin Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Luseogliflozin Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Luseogliflozin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Luseogliflozin Covered in This Study
Table 5. Global Luseogliflozin Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Luseogliflozin Sales Share by Manufacturers (2016-2021)
Table 7. Global Luseogliflozin Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Luseogliflozin Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Luseogliflozin Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Luseogliflozin Manufacturing Sites and Area Served
Table 11. Manufacturers Luseogliflozin Product Type
Table 12. Global Luseogliflozin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Luseogliflozin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Luseogliflozin as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Luseogliflozin Sales by Region (2016-2021) & (K Units)
Table 16. Global Luseogliflozin Sales Market Share by Region (2016-2021)
Table 17. Global Luseogliflozin Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Luseogliflozin Sales by Country (2016-2021) & (K Units)
Table 19. North America Luseogliflozin Sales Market Share by Country (2016-2021)
Table 20. North America Luseogliflozin Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Luseogliflozin Revenue Market Share by Country (2016-2021)
Table 22. Europe Luseogliflozin Sales by Country (2016-2021) & (K Units)
Table 23. Europe Luseogliflozin Sales Market Share by Country (2016-2021)
Table 24. Europe Luseogliflozin Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Luseogliflozin Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Luseogliflozin Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Luseogliflozin Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Luseogliflozin Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Luseogliflozin Revenue Market Share by Region (2016-2021)
Table 30. Latin America Luseogliflozin Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Luseogliflozin Sales Market Share by Country (2016-2021)
Table 32. Latin America Luseogliflozin Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Luseogliflozin Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Luseogliflozin Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Luseogliflozin Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Luseogliflozin Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Luseogliflozin Revenue Market Share by Country (2016-2021)
Table 38. Global Luseogliflozin Sales (K Units) by Type (2016-2021)
Table 39. Global Luseogliflozin Sales Market Share by Type (2016-2021)
Table 40. Global Luseogliflozin Revenue (Million US$) by Type (2016-2021)
Table 41. Global Luseogliflozin Revenue Share by Type (2016-2021)
Table 42. Global Luseogliflozin Price (US$/Unit) by Type (2016-2021)
Table 43. Global Luseogliflozin Sales (K Units) by Application (2016-2021)
Table 44. Global Luseogliflozin Sales Market Share by Application (2016-2021)
Table 45. Global Luseogliflozin Revenue (Million US$) by Application (2016-2021)
Table 46. Global Luseogliflozin Revenue Share by Application (2016-2021)
Table 47. Global Luseogliflozin Price (US$/Unit) by Application (2016-2021)
Table 48. Taisho Toyama Corporation Information
Table 49. Taisho Toyama Description and Business Overview
Table 50. Taisho Toyama Luseogliflozin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Taisho Toyama Luseogliflozin Product
Table 52. Taisho Toyama Recent Developments/Updates
Table 53. Novartis Corporation Information
Table 54. Novartis Description and Business Overview
Table 55. Novartis Luseogliflozin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Novartis Luseogliflozin Product
Table 57. Novartis Recent Developments/Updates
Table 58. Mitsubishi Tanabe Pharma Corporation Information
Table 59. Mitsubishi Tanabe Pharma Description and Business Overview
Table 60. Mitsubishi Tanabe Pharma Luseogliflozin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Mitsubishi Tanabe Pharma Luseogliflozin Product
Table 62. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 63. CR Double-Crane Corporation Information
Table 64. CR Double-Crane Description and Business Overview
Table 65. CR Double-Crane Luseogliflozin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. CR Double-Crane Luseogliflozin Product
Table 67. CR Double-Crane Recent Developments/Updates
Table 68. Production Base and Market Concentration Rate of Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Luseogliflozin Distributors List
Table 71. Luseogliflozin Customers List
Table 72. Luseogliflozin Market Trends
Table 73. Luseogliflozin Growth Drivers
Table 74. Luseogliflozin Market Restraints
Table 75. Global Luseogliflozin Sales Forecast by Type (2022-2027) & (K Units)
Table 76. Global Luseogliflozin Sales Market Share Forecast by Type (2022-2027)
Table 77. Global Luseogliflozin Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 78. Global Luseogliflozin Revenue Market Share Forecast by Type (2022-2027)
Table 79. Global Luseogliflozin Sales Forecast by Application (2022-2027) & (K Units)
Table 80. Global Luseogliflozin Sales Market Share Forecast by Application (2022-2027)
Table 81. Global Luseogliflozin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 82. Global Luseogliflozin Revenue Market Share Forecast by Application (2022-2027)
Table 83. Global Luseogliflozin Sales Forecast by Region (2022-2027) & (K Units)
Table 84. Global Luseogliflozin Sales Market Share Forecast by Region (2022-2027)
Table 85. Global Luseogliflozin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 86. Global Luseogliflozin Revenue Market Share Forecast by Region (2022-2027)
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Luseogliflozin
Figure 2. Global Luseogliflozin Market Share by Type in 2020 & 2027
Figure 3. 2.5mg Product Picture
Figure 4. 5mg Product Picture
Figure 5. Global Luseogliflozin Market Share by Application in 2020 & 2027
Figure 6. Diabetes
Figure 7. Heart Disease
Figure 8. Periodontitis
Figure 9. Global Luseogliflozin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Luseogliflozin Market Size 2016-2027 (US$ Million)
Figure 11. Global Luseogliflozin Sales 2016-2027 (K Units)
Figure 12. Global Luseogliflozin Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Luseogliflozin Sales Share by Manufacturers in 2020
Figure 14. Global Luseogliflozin Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Luseogliflozin Players: Market Share by Revenue in 2020
Figure 16. Luseogliflozin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Luseogliflozin Sales Market Share by Region (2016-2021)
Figure 18. Global Luseogliflozin Sales Market Share by Region in 2020
Figure 19. Global Luseogliflozin Revenue Market Share by Region (2016-2021)
Figure 20. Global Luseogliflozin Revenue Market Share by Region in 2020
Figure 21. U.S. Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Luseogliflozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Luseogliflozin by Type (2016-2021)
Figure 46. Sales Market Share of Luseogliflozin by Application (2016-2021)
Figure 47. Sales Market Share of Luseogliflozin by Application in 2020
Figure 48. Revenue Share of Luseogliflozin by Application (2016-2021)
Figure 49. Revenue Share of Luseogliflozin by Application in 2020
Figure 50. Manufacturing Cost Structure of Luseogliflozin
Figure 51. Manufacturing Process Analysis of Luseogliflozin
Figure 52. Luseogliflozin Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed